Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Albendazole, Tribendimidine, and Praziquantel for Clonorchiasis in Guangxi: A Randomized Controlled Trial Comparing Efficacy and Safety

NCT07074444 is registered in ClinicalTrials.gov with First Affiliated Hospital of Guangxi Medical University as lead sponsor.

NCT NCT07074444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07074444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Albendazole, Tribendimidine, and Praziquantel for Clonorchiasis in Guangxi: A Randomized Controlled Trial Comparing Efficacy and Safety
Lead sponsor
First Affiliated Hospital of Guangxi Medical University
Phase
Not applicable
Overall status
Recruiting
Start date
July 22, 2025
Completion date
February 28, 2027
Enrollment
318 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

clonorchiasis